Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-05

Clinical Trial Update: Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial update suggests a doxycycline- and furazolidone-containing quadruple regimen is superior to tailored therapy for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • doxycycline-containing quadruple regimen
  • furazolidone-containing quadruple regimen

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN